| Adult B Acute Lymphoblastic Leukemia studied in …STUDIED_INderived59 of 59show fewer |
|---|
| → studied in | NCT00792948Phase 2 · active not recruiting Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07313852Phase 1/Phase 2 · not yet recruiting A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02997761Phase 2 · completed Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03984968Phase 1/Phase 2 · active not recruiting CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07412405NA · not yet recruiting This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277504early Phase 1 · not yet recruiting Autologous Bedside CD19 CAR T-cell Therapy for B-ALL · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256353early Phase 1 · not yet recruiting Allogeneic UCB-derived CAR-T for B-ALL · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03160079Phase 1/Phase 2 · completed Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04035434Phase 1/Phase 2 · terminated A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON) · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07199855Phase 2 · active not recruiting Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06213636Phase 1/Phase 2 · recruiting Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02975687Phase 1 · completed CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462365Phase 1 · recruiting Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06696833early Phase 1 · recruiting Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788472Phase 2 · completed Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04545333terminated The clonoSEQ® Watch Registry · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01029366Phase 1 · completed CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05487651Phase 1 · unknown Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01925131Phase 1 · completed S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256398Phase 2 · completed Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214886Phase 1 · active not recruiting CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061945Phase 1/Phase 2 · completed Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375683Phase 3 · unknown Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044560Phase 2 · terminated Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059847NA · unknown Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03709719Phase 2 · active not recruiting Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075725Phase 3 · completed Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00671034Phase 3 · completed Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866307Phase 1 · completed Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04740203Phase 1/Phase 2 · unknown Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04626726early Phase 1 · unknown Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258998Phase 2 · completed Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03097770Phase 1/Phase 2 · completed Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720109Phase 2/Phase 3 · completed Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918333Phase 1/Phase 2 · completed Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036738Phase 2 · completed Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326702Phase 1/Phase 2 · completed Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110640Phase 1 · unknown Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02228772Phase 1 · completed Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408160Phase 1 · terminated Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03185494Phase 1/Phase 2 · unknown Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769209Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168907Phase 1 · terminated CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567709Phase 1 · completed Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867529Phase 2 · completed Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685670Phase 1/Phase 2 · unknown Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873093Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129062Phase 2 · terminated Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02281279Phase 1/Phase 2 · withdrawn Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864889NA · unknown Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01670084Phase 2 · withdrawn Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01735604Phase 1/Phase 2 · unknown Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02109224Phase 1 · terminated Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00608361Phase 1 · completed Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010192Phase 1 · completed Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer · condition mapped ALIAS · 59 trials mapped (12 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |